Hemangioma Thrombocytopenia Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Hemangioma Thrombocytopenia Syndrome

What is the definition of Hemangioma Thrombocytopenia Syndrome?
Hemangioma thrombocytopenia syndrome is characterized by profound thrombocytopenia in association with two rare vascular tumors: kaposiform hemangioendotheliomas and tufted angiomas. The profound thrombocytopenia can cause severe bleeding and progress to a disseminated coagulopathy in patients with these tumors.
What are the alternative names for Hemangioma Thrombocytopenia Syndrome?
  • Hemangioma thrombocytopenia syndrome
  • KMP
  • Kasabach Merritt phenomenon
  • Kasabach Merritt syndrome
  • Thrombocytopenia-hemangioma syndrome
Who are the top Hemangioma Thrombocytopenia Syndrome Local Doctors?
Distinguished in Hemangioma Thrombocytopenia Syndrome
Hematology | Oncology
Distinguished in Hemangioma Thrombocytopenia Syndrome
Hematology | Oncology
Referral may be required

Ballad Health Cancer Center

2202 North John B. Dennis Highway, Suite 100, 
Kingsport, TN 
Languages Spoken:
English, Hindi
Accepting New Patients

Asheesh Shipstone is a Hematologist and an Oncologist practicing medicine in Kingsport, Tennessee. Dr. Shipstone is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia. Dr. Shipstone is board certified in American Board Of Internal Medicine. Dr. Shipstone is currently accepting new patients.

Distinguished in Hemangioma Thrombocytopenia Syndrome
Internal Medicine
Distinguished in Hemangioma Thrombocytopenia Syndrome
Internal Medicine

Ballad Health Cancer Center - Russell County Hospital

58 Carroll St., Suite 4, 
Lebanon, VA 
Languages Spoken:
English
Accepting New Patients

Timothy Davis is a primary care provider, practicing in Internal Medicine in Lebanon, Virginia. Dr. Davis is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Familial Colorectal Cancer, and Thrombocytopenia. Dr. Davis is board certified in American Board Of Internal Medicine. Dr. Davis is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Hemangioma Thrombocytopenia Syndrome
Hematology | Oncology
Distinguished in Hemangioma Thrombocytopenia Syndrome
Hematology | Oncology
Referral required

Advocate Infusion Center

1221 N Highland Ave 1st Fl, 
Aurora, IL 
Languages Spoken:
English, Urdu
Accepting New Patients
Offers Telehealth

Mohammed Raheem is a Hematologist and an Oncologist practicing medicine in Aurora, Illinois. Dr. Raheem is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Raheem is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Raheem is currently accepting new patients.

What are the latest Hemangioma Thrombocytopenia Syndrome Clinical Trials?
Low-dose Versus High-dose Sirolimus Combined With Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: a Randomized Noninferiority Trial

Summary: This randomized clinical trial evaluates if low-dose sirolimus (target trough 4-8 ng/mL) combined with prednisolone is noninferior in efficacy but superior in safety compared to standard high-dose sirolimus (target trough 10-15 ng/mL) combined with prednisolone in pediatric patients with kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon (KHE with KMP), with participants randomized 1:...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center